Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About

Is Microsoft a Screaming Buy Under $500 Per Share?

2026/08/21

3 Reasons to Avoid OII and 1 Stock to Buy Instead

2026/08/21

SpaceX expands access to Grok Bot

2026/08/21

Jim Cramer sends strong verdict on where the market is headed

2026/08/21